Although there is a contradictory study in which APCmin /+ mice showed an increased number of polyps when subjected to a PPARγ agonist [66], many research studies have shown that PPARγ agonists seem to have inhibitory effects on the proliferation of colon cancer cells. This evidence concerns the gene PPARG and malignant colon neoplasm.